Ascentage Pharma Group International (HKG:6855)

HKG:6855 Revenue

Ascentage Pharma Group International had revenue of 302.21M CNY in the half year ending June 30, 2026, a decrease of -63.31%. This brings the company's total for the last twelve months to 642.64M, up 64.52% year-over-year. In the year 2025, Ascentage Pharma Group International had annual revenue of 574.12M, down -41.46%. That makes Ascentage Pharma Group International the 23,071st largest company in the world by revenue and 1,366th in Hong Kong.

• Revenue (ttm): 642.64M CNY
• Revenue Growth: +64.52%
• P/S Ratio: 15.15
• Revenue / Employee: 776.13K CNY
• Employees: 828
• Market Cap: 11.47B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Switzerland 678.42M 69.2%
• Chinese Mainland 302.24M 30.8%

Fiscal year ended Dec 31, 2024 See the full HKG:6855 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	574.12M	-406.53M	-41.46%
Dec 31, 2024	980.65M	758.67M	341.77%
Dec 31, 2023	221.98M	12.27M	5.85%
Dec 31, 2022	209.71M	181.80M	651.38%
Dec 31, 2021	27.91M	15.46M	124.18%
Dec 31, 2020	12.45M	-2.06M	-14.21%
Dec 31, 2019	14.51M	7.71M	113.21%
Dec 31, 2018	6.81M	479.00K	7.57%
Dec 31, 2017	6.33M	-1.34M	-17.46%
Dec 31, 2016	7.67M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Oct 19, 2026

Data Sources Report a data error